Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

Study participants were randomly assigned 2:1 to receive oral semaglutide 25mg (n=205) or placebo (n=102), as an adjunct to lifestyle intervention. The coprimary endpoints were the relative change in ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

In a new study, Ozempic - a drug sold to help with obesity and diabetes - is attributed to helping this disease.

Today, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for an investigational once-daily, 25 mg oral formulation of Wegovy® ...

Metamorphx is emerging as a leading natural GLP-1 alternative for weight loss in 2025. With prescription options like ...

A decision is expected in the fourth quarter of 2025.

As laid out by ASDA’s Online Doctor, aiding weight loss, Mounjaro is used to reduce your appetite, helping you feel fuller ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

SHOPPING: If you're ready to meet your weight goals, turn to Hims for personalized weight loss treatments that are ...

Novo Nordisk (NVO) stock in focus as oral Wegovy is accepted for FDA review for chronic weight management. Read more here.